IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells (Q40422307)

20 September 2017

title

IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells (English)

1 reference

20 September 2017

5

King-Song Jeng

1 reference

20 September 2017

Kuo-Ting Chang

1

1 reference

20 September 2017

Chun-Ming Tsai

2

1 reference

20 September 2017

Yih-Chy Chiou

3

1 reference

20 September 2017

Chao-Hua Chiu

4

1 reference

20 September 2017

Chi-Ying F Huang

6

1 reference

20 September 2017

language of work or name

1 reference

13 May 2005

1 reference

American Journal of Physiology - Lung Cellular and Molecular Physiology

20 September 2017

published in

1 reference

20 September 2017

volume

289

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

L446-53

1 reference

Neuroendocrine differentiation in prostatic carcinoma

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Neuroendocrine carcinomas of the colon and rectum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Stat proteins and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Role of IL-6 in neuroendocrine differentiation and chemosensitivity of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

STATs and Gene Regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Interleukin-6 is an autocrine growth factor in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

STATs: signal transducers and activators of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Signaling by the cytokine receptor superfamily: JAKs and STATs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Tyrphostins--potential antiproliferative agents and novel molecular tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

The paradigm of IL-6: from basic science to medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

The p38 mitogen-activated protein kinase pathway and its role in interferon signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Map kinase signaling pathways and hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Evidence for the involvement of interleukin 6 in experimental cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Serum levels of interleukin 6 in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

Neuroendocrine differentiated carcinomas of the breast: a distinct entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

PI3-K/Akt pathway contributes to IL-6-dependent growth of 7TD1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00089.2005

10.1152/AJPLUNG.00089.2005

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference